Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study my colleagues and I published in the…
Shingles vaccination rates rose during the COVID-19 pandemic, but major gaps remain for underserved groups
